The Advanced Biomarker Strategies in Oncology Drug Development is designed to provide clinical leadership from biopharma manufacturers a tool kit for the execution of successful clinical trials by focusing on challenges specific to their therapeutic area. We've selected the premier thought leaders in biomarkers, oncology drug development, and translational medicine to convene, share, and move forward the science and act as a catalyst for progress.

Top 5 Reasons to Attend

• Gain value to improve oncology drug development. 3-days of sessions that will facilitate early decision making for biomarker selection and utilization strategies, help you overcome regulatory challenges, and allow you to incorporate companion diagnostics into your plan.
• Be inspired by keynote industry analyst, Kenneth Kaitin and public health technology futurist, Thomas Goetz. Don't miss these exciting keynote presentations! Kenneth Kaitin will explore the current environment for pharmaceutical R&D and examine new approaches to improve R&D productivity. Thomas Goetz will share insights from his new book The Decision Tree and how it can be applied to the pharmaceutical marketplace to help you deliver the maximum amount of value for patients.
• Attendance is FREE. Clinical research professionals from pharmaceutical and biotech companies receive complimentary attendance. Register today to join this elite scientific community to drive innovation in oncology drug development.
• Join and network with industry experts and colleagues. Join the leading companies who have already benefited from the Target Clinical Trial Series including: Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly, Exelixis, Fred Hutchinson Cancer Research Center, Genentech, Genzyme Corporation, MedImmune , Merck, Novartis, OSI Pharmaceuticals, OncoMed Pharmaceuticals, Peregrine Pharmaceuticals, Pfizer, Roche, Sanofi Aventis Pharmaceuticals, Takeda Pharmaceuticals.
• Access the Partnering with Central Labs exhibit hall. Network with sponsors and labs responsible for the execution of safe and efficient clinical trials research. Companies you will meet include: Cardiocore, Clearstone, Clinical Reference Laboratory, CareFusion, Covance, Eurofins Medinet, ICON Central Laboratories, ICON Medical Imaging, Marken, World Courier, Cirion, ERT, ResearchDX and more!

Companies in attendance include:

Acetylon Alkermes Inc Biogen Idec Inc Cambridge Biomedical Inc Celtic Pharma Cumberland House Clinical Data Inc Daiichi Sankyo Pharma Inc Eli Lilly & Company Genentech Inc Genomic Health GlaxoSmithKline Interleukin Genetics Inc Loring Biologix Inc Merck & Company Inc

OncoMed Pharmaceuticals Inc Ore Pharmaceuticals Panacea Pharmaceuticals Inc PCI Synthesis Pfizer Pfizer Oncology Quest Diagnostics Inc Regeneron Pharmaceuticals Inc Roche Diagnostics Corporation Sanofi Aventis Pharmaceuticals Williams Cancer Drug Consulting Merrimack Pharmaceuticals Inc Novartis Pharmaceuticals Corporation and more!